US Pharma MarketingThree vaccine biotechs to be bought by Lilly for up to $3.8B
Lilly is making three acquisitions at once on Tuesday, for up to $3.8 billion total, to increase its presence in infectious disease. The pharma is buying Curevo, LimmaTech Biologics and Vaccine Company. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals…
Eli Lilly's dealmaking team must have a "that was easy" Staples button.
The world's most valuable healthcare company and maker of the biggest-selling medicine globally is putting its cash to use for its eighth, ninth ...
Source: Endpoints News